NanoMaterials2010 will take place at the Hotel Russell, London on 8-10 June. It will kick off with 3 pre-conference workshops discussing Nanomaterial SHE, Nanotechnology and Food Packaging and Characterisation and Metrology. These workshops will be

Ad - The past 3 alerts have gained up to 146% - sign up now for next month's pick.

Ad - Receive Alerts on Rising Small Cap Stocks Before the Market Opens. Sign-up Today

One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups of cells with differing genetic makeup, growth

Recent studies support the idea that the standard methods of screening men for prostate cancer leave much to be desired, particularly in terms of their inability to have much effect on prostate cancer survival. Now, a team of investigators at the

A variety of studies by numerous investigators are demonstrating that gold nanoparticles have real promise as anticancer agents. When irradiated with light, gold nanoparticles become hot quickly, hot enough to generate explosive microbubbles that will

Using nanoporous silicon particles, two teams of investigators have created drug delivery vehicles capable of ferrying labile molecular therapies deep into the body. Both groups believe their new drug delivery vehicles create new opportunities for

Professor Gabriel Aeppli, co-director of the LCN and Quain Professor of Physics in the UCL Department of Physics and Astronomy, is one of 44 new Fellows of the Royal Society elected in 2010. function google_ad_request_done(google_ads) } else } if

The hardware for a new gesture-based computing system consists of nothing more than an ordinary webcam and a pair of brightly colored lycra gloves. Photo: Jason Dorfman/CSAIL Ever since Steven Spielberg’s 2002 sci-fi movie Minority Report, in which a

Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development

The dispersion and stability of carbon nanotubes (CNTs) inside a polymer matrix, especially with a high CNT content, are still big challenges. Moreover, the interaction between CNTs and the polymer matrix should be strong enough to improve the mechanical

Shrink Nanotechnologies, Inc. ('Shrink') (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools

Ad - The past 3 alerts have gained up to 146% - sign up now for next month's pick.

CARLSBAD, Calif., BUSINESS WIRE -- Shrink Nanotechnologies, Inc. ('Shrink') (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and

Shrink Nanotechnologies, Inc. (INKN.OB) said Friday that patent applications for its stem cell research and drug discovery tool StemDisc have been filed. StemDisc is Shrink's latest bioscience application of its proprietary, patent-pending, advanced

Shrink Nanotechnologies' Biotech R&D Group Files Key Patent on StemDiscâ„¢ Biomedical Research Tool More News related to INKN More News related to Press Releases CARLSBAD, Calif.--(BUSINESS WIRE)-- Shrink Nanotechnologies, Inc. (“Shrinkâ€)

The Nanotechnology Knowledge Transfer Network (NanoKTN) has announced that its Electronic Devices and Nano Systems focus group will again be hosting a workshop at this year's S2K event in Cardiff, alongside JEMI UK. The workshop will look at the use of

GA_googleFillSlot("Press336"); GA_googleFillSlot("Press160"); CARLSBAD, Calif. - (Business Wire) Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar

StemDisc is Shrink's latest bioscience application of its proprietary, patent-pending, advanced plastic material called NanoShrink™. StemDisc offers a low cost, flexible and cost effective solution for biotech researchers to conduct experiments for (i)

StemDisc is Shrink's latest bioscience application of its proprietary, patent-pending, advanced plastic material called NanoShrink™. StemDisc offers a low cost, flexible and cost effective solution for biotech researchers to conduct experiments for (i)